This page has not been authorized, sponsored, or otherwise approved or endorsed by the companies represented herein. Each of the company logos represented herein are trademarks of Microsoft Corporation; Dow Jones & Company; Nasdaq, Inc.; Forbes Media, LLC; Investor's Business Daily, Inc.; and Morningstar, Inc.
Copyright 2024 Zacks Investment Research | 10 S Riverside Plaza Suite #1600 | Chicago, IL 60606
At the center of everything we do is a strong commitment to independent research and sharing its profitable discoveries with investors. This dedication to giving investors a trading advantage led to the creation of our proven Zacks Rank stock-rating system. Since 1988 it has more than doubled the S&P 500 with an average gain of +24.08% per year. These returns cover a period from January 1, 1988 through May 6, 2024. Zacks Rank stock-rating system returns are computed monthly based on the beginning of the month and end of the month Zacks Rank stock prices plus any dividends received during that particular month. A simple, equally-weighted average return of all Zacks Rank stocks is calculated to determine the monthly return. The monthly returns are then compounded to arrive at the annual return. Only Zacks Rank stocks included in Zacks hypothetical portfolios at the beginning of each month are included in the return calculations. Zacks Ranks stocks can, and often do, change throughout the month. Certain Zacks Rank stocks for which no month-end price was available, pricing information was not collected, or for certain other reasons have been excluded from these return calculations. Zacks may license the Zacks Mutual Fund rating provided herein to third parties, including but not limited to the issuer.
Visit Performance Disclosure for information about the performance numbers displayed above.
Visit www.zacksdata.com to get our data and content for your mobile app or website.
Real time prices by BATS. Delayed quotes by Sungard.
NYSE and AMEX data is at least 20 minutes delayed. NASDAQ data is at least 15 minutes delayed.
This site is protected by reCAPTCHA and the Google Privacy Policy, DMCA Policy and Terms of Service apply.
Zacks News
Morgan Stanley (MS) Dips More Than Broader Markets: What You Should Know
by Zacks Equity Research
Morgan Stanley (MS) closed the most recent trading day at $84.84, moving -1.06% from the previous trading session.
Should You Invest in the iShares U.S. Broker-Dealers & Securities Exchanges ETF (IAI)?
by Zacks Equity Research
Sector ETF report for IAI
Mitsubishi's (MUFG) Brokerage JV Faces Lawsuit Over Bond Sale
by Zacks Equity Research
Mitsubishi's (MUFG) brokerage joint venture, Mitsubishi UFJ Morgan Stanley Securities, faces a lawsuit by investors in Japan over the sale of AT1 bonds issued by Credit Suisse.
Morgan Stanley (MS) Stock Sinks As Market Gains: What You Should Know
by Zacks Equity Research
In the latest trading session, Morgan Stanley (MS) closed at $85.26, marking a -0.34% move from the previous day.
JPMorgan (JPM) to Increase Stake in Brazil's C6 Bank to 46%
by Zacks Equity Research
With an aim to further expand its presence in the lucrative Brazil market, JPMorgan (JPM) intends to raise its stake in C6 Bank to 46%, subject to regulatory approvals.
Is Most-Watched Stock Morgan Stanley (MS) Worth Betting on Now?
by Zacks Equity Research
Recently, Zacks.com users have been paying close attention to Morgan Stanley (MS). This makes it worthwhile to examine what the stock has in store.
Morgan Stanley (MS) Gains As Market Dips: What You Should Know
by Zacks Equity Research
Morgan Stanley (MS) closed the most recent trading day at $83.44, moving +0.06% from the previous trading session.
JPM, MS, GS & UBS Settle Stock Lending Lawsuit, to Pay $499M
by Zacks Equity Research
Goldman (GS), Morgan Stanley (MS), JPMorgan (JPM) and UBS Group (UBS) settle a lawsuit alleging rigging of the stock loans market and collectively agree to pay $499 million.
Goldman (GS) Considers Selling PFM, Will Focus on Ultra-Rich (Revised)
by Zacks Equity Research
Goldman (GS) is considering the sale of PFM, a part of its wealth management business, to focus on its ultra-high-net-worth clients. It plans to scale back its ambitions to serve the mass consumers.
Goldman (GS) Considers Selling PFM, To Focus on Ultra-Rich
by Zacks Equity Research
Goldman (GS) is considering the sale of PFM, part of its wealth management business, to focus on its ultra-high-net-worth clients. It plans to scale back its ambitions to serve mass consumers.
Citigroup (C) Mulls Corporate Overhaul, to Split ICG Division
by Zacks Equity Research
In a major corporate business restructuring, Citigroup (C) considers breaking up its ICG division into three separate segments.
Why Is Morgan Stanley (MS) Down 7.7% Since Last Earnings Report?
by Zacks Equity Research
Morgan Stanley (MS) reported earnings 30 days ago. What's next for the stock? We take a look at earnings estimates for some clues.
Morgan Stanley (MS) is Attracting Investor Attention: Here is What You Should Know
by Zacks Equity Research
Morgan Stanley (MS) has been one of the stocks most watched by Zacks.com users lately. So, it is worth exploring what lies ahead for the stock.
Morgan Stanley's (MS) Inorganic Expansion Aids Amid High Costs
by Zacks Equity Research
Morgan Stanley's (MS) strategic expansion efforts to focus less on capital markets-driven revenue sources will support profitability. However, rising expenses remain worrisome.
Top Stock Reports for JPMorgan Chase, Salesforce & Abbott Laboratories
by Sheraz Mian
Today's Research Daily features new research reports on 16 major stocks, including JPMorgan Chase & Co. (JPM), Salesforce, Inc. (CRM) and Abbott Laboratories (ABT).
Rithm Capital (RITM) Shares Dip 0.5% Despite Q2 Earnings Beat
by Zacks Equity Research
Rithm Capital's (RITM) Q2 results indicate strong contributions from the Residential Securities, Properties and Loans unit, partly offset by escalating general and administrative costs.
U.S. Bancorp (USB) Strengthens Strategic Ties With MUFG
by Zacks Equity Research
U.S. Bancorp's (USB) initiative to further bolster its strategic alliance with Mitsubishi UFJ (MUFG) will boost capital and unlock growth opportunities.
CNO Financial's (CNO) Q2 Earnings Miss on Higher Expenses
by Zacks Equity Research
CNO Financial (CNO) expects 2023 EPS in the range of $2.65-$2.85, indicating a decline from the 2022 figure of $3.06.
AMERISAFE (AMSF) Shares Fall 5.2% Despite Q2 Earnings Beat
by Zacks Equity Research
AMERISAFE's (AMSF) second-quarter results benefit from lower expenses. Improved net investment income acted as a partial offset.
Principal Financial (PFG) Q2 Earnings Miss on Higher Expenses
by Zacks Equity Research
Principal Financial's (PFG) second-quarter results are affected by deteriorating performances in most segments coupled with higher expenses.
Euronet's (EEFT) Q2 Earnings Beat on Strong epay Segment
by Zacks Equity Research
Euronet's (EEFT) Q2 results were aided by improved domestic and international cash withdrawal transactions and, promotional activity benefits, partly offset by higher direct operating expenses.
Morgan Stanley (MS) Is a Trending Stock: Facts to Know Before Betting on It
by Zacks Equity Research
Morgan Stanley (MS) has been one of the stocks most watched by Zacks.com users lately. So, it is worth exploring what lies ahead for the stock.
5 Stocks With Recent Dividend Hike to Watch Ahead of July FOMC
by Nalak Das
Dividend--paying stocks should be in demand as investors try to safeguard their portfolios. Five such stocks are: UNM, NRG, BK, MS, ATVI.
ETFs to Tap Dow Jones' Longest Winning Streak Since 2017
by Sweta Killa
Dow Jones climbed for nine consecutive sessions, marking the longest winning streak since Sep 20, 2017.
Bank Stocks' Q2 Earnings Show Consumer & Corporate Tug-of-War
by Sanghamitra Saha
Resilient consumers but a cautious corporate behavior pulled the strings on banking earnings in the second quarter.